查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1862524

產時監護設備市場按技術、應用、最終用戶、設備類型和分銷管道分類－2025-2032年全球預測

Intrapartum Monitoring Devices Market by Technology, Application, End User, Device Type, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，產時監護設備市場規模將達到 31.8 億美元，複合年成長率為 6.94%。

關鍵市場統計數據
基準年 2024 18.5億美元
預計年份：2025年 19.8億美元
預測年份 2032 31.8億美元
複合年成長率 (%) 6.94%

確定推動產時監測設備創新、改善母嬰結果並提高工作流程效率的緊迫臨床和技術要務。

產時監護設備是母胎臨床護理與不斷發展的醫療技術之間至關重要的橋樑。這些設備旨在產程中持續或間斷地監測胎心率和子宮活動，其雙重目標是在最大限度改善新生兒預後的同時，最大限度地減少不必要的干涉。近年來，該領域的生態系統已從傳統的有線系統發展到模組化、無線、軟體驅動的平台，這些平台更加重視提高數據準確性、臨床醫生工作流程效率和患者移動性。

感測器創新、無線連接和數據驅動的臨床智慧在重塑產時護理連續體中的監測模式和商業策略方面發揮著重要作用

產時監護設備領域正經歷著變革性的轉變，從核心感測技術到護理服務的操作模式都發生了翻天覆地的變化。無線遙測、新一代感測器和先進訊號處理技術的突破，使得在傳統產房之外也能進行持續、高精度的監護。同時，軟體技術的進步也為這些發展提供了有力支撐，這些軟體運用模式識別和預測分析技術處理胎兒和子宮數據，從而為臨床醫生提供更早、更準確的潛在問題預警。

了解2025年關稅變化如何推動醫療設備價值鏈的供應鏈多元化、採購調整和長期製造策略轉變。

2025年美國關稅調整為產時監護設備的製造商、經銷商和醫療採購商帶來了新的動態。直接的營運影響包括重新評估關鍵零件（例如專用感測器、印刷基板組件和無線模組）的供應鏈配置。為此，一些製造商正在加快供應商多元化，增加關鍵零件的庫存緩衝，並考慮將部分組件的生產轉移到近岸地區，以降低關稅波動帶來的風險。

將技術選擇、臨床應用、終端用戶環境、設備類別和分銷模式等多維度細分洞察轉化為可執行的產品策略。

將產時監護市場從技術、應用、終端用戶、設備類型和通路等多個維度進行整合分析，可以更細緻地觀點影響產品需求和購買行為的因素。從技術面來看，產時監護可分為外部監護和內部監護。外部監測包括胎心監測（CTG）和多普勒超音波，而內部監測包括胎兒頭皮電極和子宮內壓力導管。這些技術差異導致臨床上需要在非侵入性操作的便利性和內部感測器提供的訊號精確度之間做出權衡，從而影響急診和非急診護理環境中的採購偏好。

區域市場動態和採購行為（美洲、歐洲、中東和非洲、亞太地區）將決定產品採用路徑和商業化方式。

區域趨勢對產時監護生態系中的技術應用、採購慣例和商業策略產生了顯著影響。在美洲，對數位醫療基礎設施的投資、成熟的醫院系統以及對基於價值的醫療結果的高度重視，正在推動對能夠改善臨床工作流程和互通性的整合監護解決方案的需求。採購者往往傾向於選擇那些提供全面服務協議、臨床培訓以及能夠證明其對醫療成本產生影響的供應商，而這反過來又決定了供應商如何優先考慮認證和支援服務。

在產時監測設備市場，競爭優勢是透過檢驗的臨床平台、綜合服務產品以及能夠提升設備價值的策略夥伴關係建立起來的。

產時監護領域的競爭格局並非取決於單一功能差異，而是取決於產品系列的廣度、臨床驗證和服務生態系統。領先的製造商通常會將硬體平台與專有的訊號處理技術和使用者介面軟體結合，打造整合解決方案，從而減輕臨床醫生的認知負荷，並增強其決策信心。同時，一群新興的數位醫療公司正在提供進階分析、雲端連接和遠距監護服務，以補充傳統的設備產品。

製造商和供應商面臨的實際策略挑戰是，如何利用模組化、互聯平台來增強供應鏈韌性、檢驗臨床價值並獲得長期應用。

產業領導者應採取果斷措施，使產品開發、供應鏈韌性和市場進入策略與不斷變化的臨床和商業性預期保持一致。首先，應實現供應鏈多元化，減少對單一供應商的依賴，並投資於零件標準化，以實現替代採購，同時最大限度地減少重新認證。這種方法有助於在貿易政策變化的情況下保持產品連續性，並為醫療系統客戶提供更可預測的服務。

透明、多維度的調查方法：整合臨床醫生訪談、監管和供應鏈分析以及迭代檢驗，以確保獲得可靠且可操作的見解。

本分析的調查方法整合了多種證據來源和檢驗步驟，以確保其嚴謹性和相關性。主要研究包括對不同醫療機構的產科醫生、採購人員、醫療設備工程師和分銷合作夥伴進行結構化訪談，以收集他們對器械性能、易用性和採購因素的本地化觀點。此外，還對監管申報文件、臨床指南和同行評審文獻進行了系統性回顧，以提供文獻證據支持技術和臨床方面的論點。

從全面視角探討如何將技術進步、監管變革和供應鏈韌性轉化為產時護理中可衡量的臨床和營運改進

產時監護設備處於臨床需求與快速技術創新的交匯點，為改善產婦結局和服務創新創造了重要機會。不斷演變的醫療模式、日益嚴格的監管要求以及供應鏈重組等多重壓力，正迫使製造商提供經臨床檢驗、互通性且具有可靠性的解決方案。從臨床角度來看，無線和軟體增強型監護技術的進步有望將高品質監護的範圍擴展到傳統產房之外，同時保持訊號保真度和臨床操作便利性。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 即時人工智慧預測分析用於分娩過程中胎兒窘迫的檢測
  • 無線穿戴式母嬰監護貼片可在家庭環境中持續評估分娩進展。
  • 透過整合遠端醫療平台和產時監測設備實現虛擬產程管理
  • 利用先進的感測器融合技術進行非侵入性子宮活動監測，可提高宮縮檢測的準確性。
  • 為新興的、資源有限的醫療保健市場開發低成本、攜帶式產時監護系統
  • 一種新型薄膜電化學胎兒心電圖電極可減少訊號干擾並提高監測清晰度。
  • 雲端基礎的醫療物聯網（IoMT）解決方案整合了交付數據，以實現即時臨床決策支援儀表板。
  • 以患者為中心的行動應用程式（整合分娩過程中母親的回饋和來自產時監測設備的關鍵數據）
  • 採用生物相容性塗層的微創胎兒頭皮監測導管可降低高風險分娩期間的感染風險
  • 以超音波和子宮收縮測量相結合的混合頭盆監測技術進行分娩期全面評估的準確性

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 按技術分類的圍產期監測設備市場

  • 外部監測
    • 胎兒心音圖
    • 超音波
  • 內部監控
    • 胎兒頭皮電極
    • 子宮內壓力導管

第9章 按應用分類的產時監護設備市場

  • 持續監測
    • 固定系統
    • 無線系統
  • 間歇性監測
    • 攜帶式多普勒
    • 攜帶式顯示器

第10章 依最終用戶分類的圍產期監測設備市場

  • 門診手術中心
  • 居家醫療
  • 醫院
    • 私立醫院
    • 公立醫院
  • 婦產科中心

第11章 依設備類型分類的圍產期監測設備市場

  • 勞動監測裝置
    • 外部宮縮壓力計
    • 子宮內壓力導管
  • 胎兒監視器
    • 胎心率和產程監測
    • 多普勒胎兒分娩監視器
    • 胎兒心電圖監視器

第12章 按分銷管道分類的產時監護設備市場

  • 醫院採購
  • 線上銷售
  • 零售
  • 第三方經銷商

第13章 圍產期監測設備市場（依地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 產時監護設備市場（依類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國產時監護設備市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • General Electric Company
    • Koninklijke Philips NV
    • Baxter International Inc.
    • Dragerwerk AG & Co. KGaA
    • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • Medtronic plc
    • NIHON KOHDEN CORPORATION
    • Natus Medical Incorporated
    • Edan Instruments, Inc.
    • Huntleigh Healthcare Limited
Product Code: MRR-521BAA36EB40

The Intrapartum Monitoring Devices Market is projected to grow by USD 3.18 billion at a CAGR of 6.94% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 1.85 billion
Estimated Year [2025] USD 1.98 billion
Forecast Year [2032] USD 3.18 billion
CAGR (%) 6.94%

Framing the urgent clinical and technological imperatives driving innovation in labor monitoring systems to enhance maternal and neonatal outcomes while improving workflow efficiency

Intrapartum monitoring devices occupy a critical nexus between maternal-fetal clinical care and advancing medical technology. These devices are designed to continuously or intermittently observe fetal heart rate and uterine activity during labor, with the dual objectives of maximizing neonatal outcomes and minimizing unnecessary interventions. Over recent years, the ecosystem has evolved from legacy wired systems toward modular, wireless, and software-enabled platforms that emphasize data fidelity, clinician workflow efficiency, and improved patient mobility.

Clinical stakeholders seek devices that deliver clear, actionable signals while integrating seamlessly with electronic health record systems and delivery room workflows. At the same time, clinicians and procurement leaders demand evidence of clinical validity, ease of use, and robust infection control processes. As a result, manufacturers are balancing engineering innovation with human factors design and regulatory rigor to meet the needs of obstetric teams in varied care settings.

Transitioning from hospital-centric monitoring to hybrid care models that include ambulatory surgical centers and home healthcare settings has placed new requirements on device portability, wireless reliability, and remote monitoring capabilities. Consequently, the sector is witnessing parallel advances in sensing hardware, signal processing algorithms, and connectivity architectures. Taken together, these trends underscore a field that is both clinically indispensable and technically dynamic, creating an imperative for stakeholders to align product development, clinical validation, and go-to-market strategies around measurable improvements in safety and workflow.

How sensor innovation, wireless connectivity, and data-driven clinical intelligence are reshaping monitoring paradigms and commercial strategies across the intrapartum care continuum

The intrapartum monitoring landscape is undergoing transformative shifts that extend from core sensing technologies to the operational models of care delivery. Technological breakthroughs in wireless telemetry, next-generation sensors, and advanced signal processing are enabling continuous, high-fidelity monitoring outside the confines of the traditional delivery suite. These developments are complemented by software advances that apply pattern recognition and predictive analytics to fetal and uterine data, offering clinicians earlier and more precise alerts of potential compromise.

Simultaneously, care delivery is being reconfigured by the growth of decentralized models: fixed monitoring systems remain central to tertiary hospitals, while wireless and portable solutions enable monitoring in ambulatory surgical centers, maternity centers, and home settings. Payers and health systems emphasizing value-based care are prioritizing devices that demonstrate reductions in avoidable interventions and improved throughput. In regulatory terms, authorities are increasingly focused on software quality, cybersecurity, and interoperability standards, compelling vendors to incorporate compliance by design.

Market participants are also reshaping commercial strategies through collaborations between traditional medical device manufacturers and digital health companies to combine hardware reliability with cloud-native analytics. As a result, product roadmaps are prioritizing user-centered interfaces, secure data transmission, and clinical validation pathways that prove real-world utility. In short, the convergence of sensor innovation, connectivity, and data science is redefining what intrapartum monitoring can deliver for clinicians and expectant families.

Understanding how 2025 tariff revisions are catalyzing supply chain diversification, procurement adjustments, and longer term manufacturing strategy shifts in the medical device value chain

The 2025 tariff adjustments in the United States have introduced a new set of dynamics for manufacturers, distributors, and healthcare purchasers of intrapartum monitoring devices. The immediate operational effect has been a reassessment of supply chain configurations for critical components such as specialized sensors, printed circuit assemblies, and wireless modules. In response, several manufacturers have accelerated diversification of supplier bases, increased inventory buffers for key parts, and evaluated nearshoring for subassemblies to reduce exposure to tariff volatility.

These supply chain responses have downstream implications for procurement cycles and contract negotiations. Hospitals and maternity centers are placing greater emphasis on supplier resilience and transparent cost breakdowns during tendering. Meanwhile, distributors are renegotiating terms with suppliers to preserve service levels, and logistics partners are adapting routing to mitigate customs-related delays. Over time, these adaptations influence product roadmaps by shifting component selection toward parts with more stable sourcing profiles and by encouraging modular designs that can accept alternative supplier inputs with minimal requalification overhead.

Finally, the policy environment has catalyzed conversations about domestic manufacturing incentives, which some manufacturers view as an opportunity to align regulatory, quality, and procurement advantages. While relocation and retooling require capital and regulatory revalidation, the longer-term strategic benefit may include shortened lead times, reduced tariff exposure, and stronger relationships with domestic health systems that prioritize locally produced medical technologies. In essence, tariffs have prompted a strategic reassessment across the value chain that favors resilience, flexibility, and supplier transparency.

Interpreting multidimensional segmentation insights that connect technology choices, clinical applications, end-user environments, device categories, and distribution models into actionable product strategies

A nuanced view of the intrapartum monitoring market emerges when the landscape is structured by technology, application, end user, device type, and distribution pathways as integrated dimensions that shape product requirements and buyer behavior. From a technology perspective, the market is studied across external monitoring and internal monitoring; external approaches encompass cardiotocography and Doppler ultrasonography while internal approaches include fetal scalp electrodes and intrauterine pressure catheters. These technological distinctions create differing clinical trade-offs between noninvasive ease-of-use and the signal fidelity afforded by internal sensors, which in turn inform procurement preferences in high-acuity versus lower-acuity settings.

When analyzed by application, the market is studied across continuous monitoring and intermittent monitoring. Continuous monitoring displays a bifurcation between fixed systems that anchor delivery suite monitoring and wireless systems that enable mobility and remote oversight. Intermittent monitoring includes handheld Doppler devices and portable monitors that support routine checks and community-based care. The choice between continuous and intermittent approaches reflects clinical protocols, staff availability, and the care setting's tolerance for investment in infrastructure.

Examining end users clarifies deployment patterns across ambulatory surgical centers, home healthcare providers, hospitals, and maternity centers; within hospitals, distinctions between private and public institutions influence procurement cycles, budgetary constraints, and service expectations. Device type further refines product positioning as the market is studied across contraction monitoring devices and fetal monitoring devices. Contraction monitoring is differentiated into external tocodynamometers and intrauterine pressure catheters, while fetal monitoring encompasses cardiotocography monitors, Doppler fetal monitors, and fetal ECG monitors, each offering distinct trade-offs in fidelity, invasiveness, and clinical applicability.

Lastly, distribution channel dynamics-spanning hospital purchase, online sales, retail sales, and third-party distributors-shape availability, post-sale service expectations, and pricing strategies. Integrated manufacturers with direct hospital relationships often emphasize installation and training, whereas online and retail channels prioritize ease of ordering and rapid delivery. Taken together, these segmentation lenses reveal that successful offerings must be engineered and marketed in ways that reflect the interplay of clinical requirements, procurement complexity, and distribution realities.

Regional market dynamics and procurement behaviors across the Americas, Europe Middle East & Africa, and Asia-Pacific that determine adoption pathways and commercialization approaches

Regional dynamics exert a strong influence on technology adoption, procurement practices, and commercial strategy across the intrapartum monitoring ecosystem. In the Americas, investment in digital health infrastructure, mature hospital systems, and a strong emphasis on value-based outcomes drive demand for integrated monitoring solutions that can demonstrate improved clinical workflows and interoperability. Procurement tends to favor vendors that provide comprehensive service agreements, clinical training, and evidence of cost-of-care impact, which informs how suppliers prioritize certifications and support offerings.

In Europe, the Middle East, and Africa, regulatory harmonization across parts of Europe is balanced by heterogeneous procurement norms and budget constraints in many markets. Public healthcare purchasers often emphasize total cost of ownership and long procurement cycles, whereas private maternity centers may pursue differentiated technology to attract patients. Across the region, data privacy and cybersecurity requirements shape product development priorities, and multinational suppliers must tailor compliance approaches to local regulatory frameworks.

The Asia-Pacific region is characterized by rapid adoption in urban centers, a strong supplier and manufacturing presence, and an expanding private healthcare sector that demands both advanced technologies and cost-effective models. Rural and peri-urban care settings in several markets present opportunities for portable and low-power devices that enable decentralized monitoring. As a result, product strategies that include tiered features, localized technical support, and supply chain partnerships are especially effective in driving adoption across diverse geographies. Across all regions, cross-border trade dynamics and regulatory alignment play decisive roles in how companies deploy resources and prioritize market entry.

How competitive advantage in the intrapartum monitoring market is built through validated clinical platforms, integrated service offerings, and strategic partnerships that extend device value

Competitive dynamics in intrapartum monitoring are shaped less by single-feature differentiation and more by portfolio breadth, clinical validation, and service ecosystems. Leading manufacturers often combine hardware platforms with proprietary signal processing and user interface software to create integrated solutions that reduce clinician cognitive load and enhance decision confidence. Meanwhile, an emerging cohort of digital health firms contributes advanced analytics, cloud connectivity, and remote monitoring services that complement traditional device offerings.

Companies are increasingly pursuing hybrid commercial models that mix direct hospital sales with channel partnerships, online ordering, and distributor networks to address varied procurement preferences. In parallel, investment in clinical evidence generation-through observational studies, randomized trials, and real-world evidence collection-has become a central competitive lever, providing the foundation for guideline inclusion and payer conversations. Aftermarket services such as training programs, preventive maintenance, and device-as-a-service options are differentiators that strengthen customer retention and create recurring revenue streams.

Finally, strategic alliances between device manufacturers and health systems, software vendors, or contract manufacturers are accelerating time-to-market and expanding capability stacks. These alliances enable faster regulatory pathways for combined hardware-software propositions, allow access to complementary sales channels, and support the scaling of remote monitoring services. Collectively, these company-level approaches emphasize the importance of clinical validation, service excellence, and ecosystem partnerships in sustaining competitive advantage.

Practical strategic imperatives for manufacturers and suppliers to bolster supply resilience, validate clinical value, and leverage modular, connected platforms to win long-term adoption

Industry leaders should take decisive steps to align product development, supply chain resilience, and market access strategies with evolving clinical and commercial expectations. First, diversify supply chains to reduce single-source exposure and invest in component standardization to enable alternative sourcing without extensive requalification. This approach preserves product continuity in the face of trade policy shifts and supports more predictable service commitments to health system customers.

Second, prioritize investments in wireless connectivity, cybersecurity, and cloud-enabled analytics to support remote monitoring and telehealth workflows. These capabilities must be paired with rigorous clinical validation and transparent performance metrics to earn clinician trust. Third, design modular product architectures that allow incremental upgrades in software and sensing capabilities; modularity reduces upgrade costs for customers and accelerates the deployment of new analytical features.

Fourth, engage proactively with payers and health system procurement teams to build reimbursement narratives grounded in clinical outcomes and operational efficiency. Demonstrable reductions in unnecessary interventions, improved throughput, and better patient experience will be central to those conversations. Fifth, expand service offerings to include training, preventative maintenance, and outcome-driven support contracts that align vendor incentives with clinical success. Finally, accelerate partnerships with digital health firms, academic centers, and local manufacturing partners to combine clinical credibility, analytic capability, and supply chain flexibility. These strategic moves create a durable foundation for growth and resilience in a shifting policy and clinical environment.

A transparent, multi-method research framework combining clinician interviews, regulatory and supply chain analysis, and iterative validation to ensure robust actionable insights

The research methodology underpinning this analysis integrates multiple evidence streams and validation steps to ensure rigor and relevance. Primary research included structured interviews with obstetric clinicians, procurement leaders, biomedical engineers, and distribution partners across varied healthcare settings to capture frontline perspectives on device performance, usability, and procurement drivers. These qualitative inputs were complemented by systematic reviews of regulatory filings, clinical guidelines, and peer-reviewed literature to ground technological and clinical claims in documented evidence.

To map supply chain dynamics and tariff impacts, the methodology incorporated supplier mapping exercises, trade flow analyses, and input from logistics specialists to identify points of vulnerability and common mitigation strategies. Data triangulation techniques were employed to reconcile divergent inputs and validate assumptions. In addition, scenario testing and sensitivity analyses were used to examine how changes in procurement preferences, care models, and policy shifts could alter strategic priorities for stakeholders.

Quality assurance included cross-validation workshops with external clinical advisors and technical reviewers, as well as iterative checks for internal consistency and traceability to source data. Limitations and uncertainties were explicitly documented, and where evidence gaps existed, the analysis identified high-priority areas for further primary study. Overall, the methodology emphasizes transparency, multi-stakeholder validation, and a balance between technical detail and strategic applicability.

Concluding perspectives on translating technological advances, regulatory changes, and supply resilience into measurable clinical and operational improvements in intrapartum care

Intrapartum monitoring devices stand at the intersection of clinical necessity and rapid technological change, creating significant opportunities for improved outcomes and service innovation. The combined pressures of evolving care models, heightened regulatory expectations, and supply chain realignment are pushing manufacturers to deliver solutions that are clinically validated, interoperable, and resilient. From a clinical perspective, the move toward wireless, software-enhanced monitoring offers the potential to extend high-quality oversight beyond the traditional delivery room while preserving signal fidelity and clinician usability.

Commercially, companies that integrate hardware reliability with advanced analytics, flexible service models, and demonstrated outcome improvements will be best positioned to succeed. Procurement stakeholders will increasingly reward transparent supply chains, strong post-sale support, and clear evidence of impact on care pathways. As stakeholders adapt to policy changes and shifting care delivery models, collaboration across clinical, technical, and commercial domains will be essential. Ultimately, the path forward requires a disciplined focus on clinical evidence, system interoperability, and supply chain adaptability to translate technological promise into measurable improvements in maternal and neonatal care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Real-time AI-powered predictive analytics for fetal distress detection during labor
  • 5.2. Wireless wearable maternal and fetal monitoring patch enabling continuous labor assessment in home settings
  • 5.3. Integration of remote telehealth platforms with intrapartum monitoring devices for virtual labor management
  • 5.4. Non-invasive uterine activity monitoring using advanced sensor fusion for enhanced contraction detection accuracy
  • 5.5. Development of low-cost portable intrapartum monitoring systems for resource-limited and emerging healthcare markets
  • 5.6. Novel thin-film electrochemical fetal ECG electrodes reducing signal interference and improving monitoring clarity
  • 5.7. Cloud-based Internet of Medical Things solutions aggregating labor data for real-time clinical decision support dashboards
  • 5.8. Patient-centric mobile applications integrating maternal feedback and biometric data from intrapartum monitoring devices
  • 5.9. Minimally invasive fetal scalp monitoring catheters with biocompatible coatings reducing infection risk during high-risk deliveries
  • 5.10. Hybrid cephalopelvic monitoring combining ultrasound and tocodynamometry for comprehensive intrapartum assessment accuracy

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Intrapartum Monitoring Devices Market, by Technology

  • 8.1. External Monitoring
    • 8.1.1. Cardiotocography
    • 8.1.2. Doppler Ultrasonography
  • 8.2. Internal Monitoring
    • 8.2.1. Fetal Scalp Electrode
    • 8.2.2. Intrauterine Pressure Catheter

9. Intrapartum Monitoring Devices Market, by Application

  • 9.1. Continuous Monitoring
    • 9.1.1. Fixed Systems
    • 9.1.2. Wireless Systems
  • 9.2. Intermittent Monitoring
    • 9.2.1. Handheld Doppler
    • 9.2.2. Portable Monitors

10. Intrapartum Monitoring Devices Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Home Healthcare
  • 10.3. Hospitals
    • 10.3.1. Private Hospital
    • 10.3.2. Public Hospital
  • 10.4. Maternity Centers

11. Intrapartum Monitoring Devices Market, by Device Type

  • 11.1. Contraction Monitoring Device
    • 11.1.1. External Tocodynamometer
    • 11.1.2. Intrauterine Pressure Catheter
  • 11.2. Fetal Monitoring Device
    • 11.2.1. Cardiotocography Monitors
    • 11.2.2. Doppler Fetal Monitors
    • 11.2.3. Fetal ECG Monitors

12. Intrapartum Monitoring Devices Market, by Distribution Channel

  • 12.1. Hospital Purchase
  • 12.2. Online Sales
  • 12.3. Retail Sales
  • 12.4. Third-Party Distributors

13. Intrapartum Monitoring Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Intrapartum Monitoring Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Intrapartum Monitoring Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. General Electric Company
    • 16.3.2. Koninklijke Philips N.V.
    • 16.3.3. Baxter International Inc.
    • 16.3.4. Dragerwerk AG & Co. KGaA
    • 16.3.5. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • 16.3.6. Medtronic plc
    • 16.3.7. NIHON KOHDEN CORPORATION
    • 16.3.8. Natus Medical Incorporated
    • 16.3.9. Edan Instruments, Inc.
    • 16.3.10. Huntleigh Healthcare Limited

LIST OF FIGURES

  • FIGURE 1. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. INTRAPARTUM MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. INTRAPARTUM MONITORING DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. INTRAPARTUM MONITORING DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY EXTERNAL MONITORING, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY EXTERNAL MONITORING, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY EXTERNAL MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY EXTERNAL MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY EXTERNAL MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY EXTERNAL MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY EXTERNAL MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY EXTERNAL MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CARDIOTOCOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CARDIOTOCOGRAPHY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CARDIOTOCOGRAPHY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CARDIOTOCOGRAPHY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CARDIOTOCOGRAPHY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CARDIOTOCOGRAPHY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DOPPLER ULTRASONOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DOPPLER ULTRASONOGRAPHY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DOPPLER ULTRASONOGRAPHY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DOPPLER ULTRASONOGRAPHY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DOPPLER ULTRASONOGRAPHY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DOPPLER ULTRASONOGRAPHY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERNAL MONITORING, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERNAL MONITORING, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERNAL MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERNAL MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERNAL MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERNAL MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERNAL MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERNAL MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL SCALP ELECTRODE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL SCALP ELECTRODE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL SCALP ELECTRODE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL SCALP ELECTRODE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL SCALP ELECTRODE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL SCALP ELECTRODE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTRAUTERINE PRESSURE CATHETER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTRAUTERINE PRESSURE CATHETER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTRAUTERINE PRESSURE CATHETER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTRAUTERINE PRESSURE CATHETER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTRAUTERINE PRESSURE CATHETER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTRAUTERINE PRESSURE CATHETER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTINUOUS MONITORING, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTINUOUS MONITORING, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTINUOUS MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTINUOUS MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTINUOUS MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTINUOUS MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTINUOUS MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTINUOUS MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FIXED SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FIXED SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FIXED SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FIXED SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FIXED SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FIXED SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY WIRELESS SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY WIRELESS SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY WIRELESS SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY WIRELESS SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY WIRELESS SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY WIRELESS SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERMITTENT MONITORING, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERMITTENT MONITORING, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERMITTENT MONITORING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERMITTENT MONITORING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERMITTENT MONITORING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERMITTENT MONITORING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERMITTENT MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERMITTENT MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HANDHELD DOPPLER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HANDHELD DOPPLER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HANDHELD DOPPLER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HANDHELD DOPPLER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HANDHELD DOPPLER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HANDHELD DOPPLER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY PORTABLE MONITORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY PORTABLE MONITORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY PORTABLE MONITORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY PORTABLE MONITORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY PORTABLE MONITORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY PORTABLE MONITORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY PRIVATE HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY PRIVATE HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY PRIVATE HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY PRIVATE HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY PUBLIC HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY PUBLIC HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY PUBLIC HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY PUBLIC HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY MATERNITY CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY MATERNITY CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY MATERNITY CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY MATERNITY CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY MATERNITY CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY MATERNITY CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTRACTION MONITORING DEVICE, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTRACTION MONITORING DEVICE, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTRACTION MONITORING DEVICE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTRACTION MONITORING DEVICE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTRACTION MONITORING DEVICE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTRACTION MONITORING DEVICE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTRACTION MONITORING DEVICE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTRACTION MONITORING DEVICE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY EXTERNAL TOCODYNAMOMETER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY EXTERNAL TOCODYNAMOMETER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY EXTERNAL TOCODYNAMOMETER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY EXTERNAL TOCODYNAMOMETER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY EXTERNAL TOCODYNAMOMETER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY EXTERNAL TOCODYNAMOMETER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTRAUTERINE PRESSURE CATHETER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTRAUTERINE PRESSURE CATHETER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTRAUTERINE PRESSURE CATHETER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTRAUTERINE PRESSURE CATHETER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTRAUTERINE PRESSURE CATHETER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTRAUTERINE PRESSURE CATHETER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL MONITORING DEVICE, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL MONITORING DEVICE, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL MONITORING DEVICE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL MONITORING DEVICE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL MONITORING DEVICE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL MONITORING DEVICE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL MONITORING DEVICE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL MONITORING DEVICE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CARDIOTOCOGRAPHY MONITORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CARDIOTOCOGRAPHY MONITORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CARDIOTOCOGRAPHY MONITORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CARDIOTOCOGRAPHY MONITORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CARDIOTOCOGRAPHY MONITORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CARDIOTOCOGRAPHY MONITORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DOPPLER FETAL MONITORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DOPPLER FETAL MONITORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DOPPLER FETAL MONITORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DOPPLER FETAL MONITORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DOPPLER FETAL MONITORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DOPPLER FETAL MONITORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL ECG MONITORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL ECG MONITORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL ECG MONITORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL ECG MONITORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL ECG MONITORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL ECG MONITORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOSPITAL PURCHASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOSPITAL PURCHASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOSPITAL PURCHASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOSPITAL PURCHASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOSPITAL PURCHASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOSPITAL PURCHASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY ONLINE SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY ONLINE SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY RETAIL SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY RETAIL SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY RETAIL SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY RETAIL SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY RETAIL SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY RETAIL SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 206. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 207. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 208. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 209. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY EXTERNAL MONITORING, 2018-2024 (USD MILLION)
  • TABLE 210. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY EXTERNAL MONITORING, 2025-2032 (USD MILLION)
  • TABLE 211. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERNAL MONITORING, 2018-2024 (USD MILLION)
  • TABLE 212. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERNAL MONITORING, 2025-2032 (USD MILLION)
  • TABLE 213. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 214. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 215. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTINUOUS MONITORING, 2018-2024 (USD MILLION)
  • TABLE 216. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTINUOUS MONITORING, 2025-2032 (USD MILLION)
  • TABLE 217. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERMITTENT MONITORING, 2018-2024 (USD MILLION)
  • TABLE 218. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERMITTENT MONITORING, 2025-2032 (USD MILLION)
  • TABLE 219. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 220. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 221. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 222. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 223. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 224. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 225. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTRACTION MONITORING DEVICE, 2018-2024 (USD MILLION)
  • TABLE 226. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTRACTION MONITORING DEVICE, 2025-2032 (USD MILLION)
  • TABLE 227. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL MONITORING DEVICE, 2018-2024 (USD MILLION)
  • TABLE 228. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL MONITORING DEVICE, 2025-2032 (USD MILLION)
  • TABLE 229. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 230. AMERICAS INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 234. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 235. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY EXTERNAL MONITORING, 2018-2024 (USD MILLION)
  • TABLE 236. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY EXTERNAL MONITORING, 2025-2032 (USD MILLION)
  • TABLE 237. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERNAL MONITORING, 2018-2024 (USD MILLION)
  • TABLE 238. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERNAL MONITORING, 2025-2032 (USD MILLION)
  • TABLE 239. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 240. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 241. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTINUOUS MONITORING, 2018-2024 (USD MILLION)
  • TABLE 242. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTINUOUS MONITORING, 2025-2032 (USD MILLION)
  • TABLE 243. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERMITTENT MONITORING, 2018-2024 (USD MILLION)
  • TABLE 244. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERMITTENT MONITORING, 2025-2032 (USD MILLION)
  • TABLE 245. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 246. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 247. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 248. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 251. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTRACTION MONITORING DEVICE, 2018-2024 (USD MILLION)
  • TABLE 252. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTRACTION MONITORING DEVICE, 2025-2032 (USD MILLION)
  • TABLE 253. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL MONITORING DEVICE, 2018-2024 (USD MILLION)
  • TABLE 254. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL MONITORING DEVICE, 2025-2032 (USD MILLION)
  • TABLE 255. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 256. NORTH AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 257. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 260. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 261. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY EXTERNAL MONITORING, 2018-2024 (USD MILLION)
  • TABLE 262. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY EXTERNAL MONITORING, 2025-2032 (USD MILLION)
  • TABLE 263. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERNAL MONITORING, 2018-2024 (USD MILLION)
  • TABLE 264. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERNAL MONITORING, 2025-2032 (USD MILLION)
  • TABLE 265. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 266. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 267. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTINUOUS MONITORING, 2018-2024 (USD MILLION)
  • TABLE 268. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTINUOUS MONITORING, 2025-2032 (USD MILLION)
  • TABLE 269. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERMITTENT MONITORING, 2018-2024 (USD MILLION)
  • TABLE 270. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY INTERMITTENT MONITORING, 2025-2032 (USD MILLION)
  • TABLE 271. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 272. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 273. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 274. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 275. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 276. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 277. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTRACTION MONITORING DEVICE, 2018-2024 (USD MILLION)
  • TABLE 278. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY CONTRACTION MONITORING DEVICE, 2025-2032 (USD MILLION)
  • TABLE 279. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL MONITORING DEVICE, 2018-2024 (USD MILLION)
  • TABLE 280. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY FETAL MONITORING DEVICE, 2025-2032 (USD MILLION)
  • TABLE 281. LATIN AMERICA INTRAPARTUM MONITORING DEVICES MARKET SIZE, BY DISTRIBUTIO